A plan with purpose.
Nutrition, movement and clinically appropriate medication can be considered together. The plan starts with an individual evaluation.
Growth hormone, recovery and other peptide goals deserve more than an isolated prescription. Individual evaluation, clear protocols and ongoing review.

Nutrition, movement and clinically appropriate medication can be considered together. The plan starts with an individual evaluation.
Body composition, recovery and hormone-related goals inform the conversation. A shared assessment does not make every treatment necessary.
Regular review considers progress, tolerability and changing needs. No result or prescription is guaranteed.
Care begins with evaluation—not a universal peptide prescription. Specific treatment availability requires clinic confirmation.
Two lead protocols. Each treatment has its own indication.

Recovery, sleep and body-composition goals deserve a considered conversation. Growth-hormone-related care begins with clinical rationale, not a routine addition to testosterone therapy.
Growth hormone evaluation is distinct from GH replacement. Compounded GH-releasing therapies such as sermorelin are not FDA-approved. No general sleep, testosterone or physique benefit is promised; confirmed GH deficiency is a specialist pathway.
Book NowExplore connected care
Training load, injuries, sleep and medical history shape the recovery conversation. Peptide options are considered alongside the care you already have, not as a shortcut.
Many peptides discussed for recovery have limited human evidence and are not FDA-approved; compounded preparations are not FDA-approved. A recovery category is not proof that a peptide speeds healing. Exact ingredients, risks and lawful availability are reviewed by your provider.
Book NowPeptide questions answeredA plan that considers training load, sleep and medical history alongside any medication—not medication in isolation.
Training, nutrition and body-composition goals can inform care without assuming a particular treatment outcome.
Follow-up gives the provider a chance to review progress, tolerability and whether the plan still fits.
These are care goals, not promised results. Treatment suitability, benefits, risks and response vary by individual.
The Tide’s additional care topics remain available for discussion—not automatic additions to a hormone plan.

A clinical conversation about related concerns and the care already in place.
The category does not identify an ingredient or establish that a capsule treats inflammation. Evidence, risks and alternatives are reviewed individually.

Sleep routines, rest and relevant health history belong in the same conversation.
Possible causes of sleep concerns deserve evaluation first. A peptide category is not an established insomnia treatment or a promised sleep result.

A closer look at cellular-signaling research—and what it can actually tell clinicians.
Early research does not establish energy, weight-loss or longevity benefits in people. Exact ingredient identity, safety and availability require separate review.

Clear questions about concentration, routines and appropriate next steps.
The category is not an ingredient name or an established cognitive treatment. Evidence, route-specific risks and alternatives must be discussed.

A related cellular-health conversation. NAD+ is a coenzyme, not a peptide.
Its cellular role does not establish benefits from injections. Formulation quality, adverse-reaction risks and evidence require review; compounded preparations are not FDA-approved.

Sexual-health goals deserve an individualized medical conversation.
Formulation and route matter. Evidence for an injectable product does not transfer to a nasal preparation; suitability and blood-pressure risks require review.
Category names are not ingredient identities or confirmation of stock. Some investigational preparations have limited human evidence. Compounded medications are not FDA-approved; exact ingredients, risks, alternatives and lawful availability require provider review.
Sleep, training, recovery and hormone health add context. No single peptide replaces the whole clinical picture.
Self-pay. No insurance billing. HSA/FSA eligibility depends on the individual plan. The clinic confirms the complete cost before care begins.
View all pricingMedications and testing are separate. Most peptide treatments are $99–$249, depending on your goal. The clinic confirms the individual product, testing, follow-up and total price before you start.
Book NowReview medical history, metabolic factors and relevant findings to identify the appropriate care pathway.
Discuss evidence, approval status, risks and alternatives. Refer for specialist endocrine assessment when indicated.
If treatment is indicated, monitor tolerability and relevant clinical measures, then reassess whether the plan remains appropriate.
Context matters. These answers explain the care approach, not an individual treatment recommendation.
Most peptide treatments are $99–$249, depending on your goal and the medication prescribed. The $49 first consultation is separate, and the clinic confirms the full price before you start.
Most are not. Many peptides discussed for recovery have limited human evidence, and compounded preparations are not FDA-approved. Your provider reviews the evidence, risks, alternatives and lawful availability with you.
Diagnosed adult GH deficiency warrants specialist evaluation, often including stimulation testing. An age-related decline or single screening result is not a diagnosis. GH replacement is an endocrinology pathway, separate from compounded GH-releasing options.
No. Peptide therapy, testosterone treatment and growth hormone care each require independent decisions. A coordinated assessment may lead to one pathway, several separately indicated therapies or no medication.
“For the first time, I felt really heard about my concerns.”
“I felt truly helped, educated and properly prepared for my future health journey.”
“It’s not one-size-fits-all, it’s catered to you.”
Excerpts from Google reviews. Individual results vary.
Houston clinic. Texas telehealth.